Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
18
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | MSD | Health | Health Policy (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | MSD | Finance | R&D Tax Credit (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | To highlight to the new Minister of Finance MSD Ireland finance related health policy matters. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Meeting to discuss pharma industry in Ireland and importance of (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Continued importance of a competitive and favorable business environment in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines Funding in Budget 2024 (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Vaccination programmes (Matters involving public funds) | 3 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Reimbursement of innovative medicines and vaccines (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Finance | Taxation and Foreign Direct Investment (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| May–Aug 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2019 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Attendance at the World Economic Forum (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 14 | 77.8% | |
| Economic Development and Industry | 2 | 11.1% | |
| Finance | 2 | 11.1% |